Suppr超能文献

上皮性卵巢癌研究中关于外泌体的当前趋势:一项文献计量学综述

The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review.

作者信息

Baghban Neda, Ullah Mujib, Nabipour Iraj

机构信息

The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.

Institute for Immunity and Transplantation, Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Palo Alto, CA, United States.

出版信息

Front Pharmacol. 2023 Mar 9;14:1082066. doi: 10.3389/fphar.2023.1082066. eCollection 2023.

Abstract

Epithelial ovarian cancer (EOC) is the most common type of ovarian cancer. About 90% of ovary tumors are epithelial. The current treatment for EOC involves surgical debulking of the tumors followed by a combination of chemotherapy. While most patients achieve complete remission, many EOCs will recur and develop chemoresistance. The cancer cells can adapt to several stress stimuli, becoming resistant. Therefore, new ways to fight resistant cells during the disease are being studied. Recently, exosomes, which reflect cell behavior in normal and pathological conditions such as epithelial ovarian cancer, are of academic interest as new biomarkers for diagnosis and therapy. Consequently, the current study aimed to investigate the research output of exosomes in EOC. A bibliometric method was used for analyzing publications on exosome and epithelial ovarian cancer from the beginning to 15 October 2022 by searching keywords in Scopus, PubMed and Google scholar. Annual scientific publications, authors, citations, journals, co-authorships, and keywords co-occurrence were analyzed and plotted using Microsoft Office Excel and VOS viewer. 39 original journal articles and 3 reviews have been published since 2015 up to 15 October 2022. The findings showed that China is the top country in research output, international collaborations, organization, author, and sponsorship. The top journals were the Journal of Ovarian Research, Oncotarget, and Tumor Biology, all in the United States. The top institution was Shanghai Jiao Tong University in China. The top author was Xipeng Wang. Co-occurrence analysis showed that academics' interest is toward:1) 1) Exosomes as prognostic biomarkers of EOC as well as their role in the proliferation and migration of cells. 2) The role of exosomes in metastasis through different mechanisms; 3) The role of exosomes in epithelial-mesenchymal transition of ovarian cancer cells; 4) The diagnostic role of EVs in EOC; and 5) Conferring chemoresistance in EOC through the exosomal transfer of miRNAs. Research on the exosome and EOC has an increasing trend, and China is much more involved than other countries in research, financial support, and international cooperation. These findings could aid researcher in understanding novel ideas and subjects interested by sponsors in this field.

摘要

上皮性卵巢癌(EOC)是最常见的卵巢癌类型。约90%的卵巢肿瘤为上皮性肿瘤。目前EOC的治疗方法包括对肿瘤进行手术减瘤,随后进行化疗联合治疗。虽然大多数患者实现了完全缓解,但许多EOC仍会复发并产生化疗耐药性。癌细胞可以适应多种应激刺激,从而产生耐药性。因此,正在研究在疾病期间对抗耐药细胞的新方法。最近,外泌体作为正常和病理条件下(如上皮性卵巢癌)细胞行为的反映,作为诊断和治疗的新生物标志物引起了学术关注。因此,本研究旨在调查外泌体在EOC中的研究成果。采用文献计量学方法,通过在Scopus、PubMed和谷歌学术中搜索关键词,分析了从开始到2022年10月15日关于外泌体和上皮性卵巢癌的出版物。使用Microsoft Office Excel和VOS viewer分析并绘制年度科学出版物、作者、引用、期刊、共同作者以及关键词共现情况。从2015年到2022年10月15日,共发表了39篇原创期刊文章和3篇综述。研究结果表明,中国在研究产出、国际合作、机构、作者和资助方面位居榜首。排名靠前的期刊是美国的《卵巢研究杂志》《肿瘤靶向》和《肿瘤生物学》。排名靠前的机构是中国的上海交通大学。排名靠前的作者是王西鹏。共现分析表明,学术界的兴趣在于:1)外泌体作为EOC的预后生物标志物及其在细胞增殖和迁移中的作用。2)外泌体通过不同机制在转移中的作用;3)外泌体在卵巢癌细胞上皮-间质转化中的作用;4)细胞外囊泡在EOC中的诊断作用;5)通过外泌体转移miRNA赋予EOC化疗耐药性。关于外泌体和EOC的研究呈上升趋势,中国在研究、资金支持和国际合作方面比其他国家参与度更高。这些发现有助于研究人员了解该领域资助者感兴趣的新观点和主题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af5/10034012/acb4e61c0f34/fphar-14-1082066-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验